ELAN
NYSEElanco Animal Health Incorporated
Website
News25/Ratings12
News · 26 weeks109-52%
2025-10-262026-04-19
Mix5990d
- Insider45(76%)
- Other7(12%)
- SEC Filings4(7%)
- Earnings2(3%)
- Analyst1(2%)
Latest news
25 items- INSIDERSEC Form 4 filed by Simmons Jeffrey N4 - Elanco Animal Health Inc (0001739104) (Issuer)
- INSIDERSEC Form 4 filed by Vanhimbergen Robert M4 - Elanco Animal Health Inc (0001739104) (Issuer)
- INSIDERSEC Form 4 filed by Modi Rajeev A.4 - Elanco Animal Health Inc (0001739104) (Issuer)
- PRElanco Confirms Date and Conference Call for First Quarter 2026 Financial Results AnnouncementINDIANAPOLIS, April 16, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE:ELAN) will announce its first quarter 2026 financial results on Wednesday, May 6, 2026. Elanco will also conduct a conference call on that day with the investment community and media to further detail the company's performance. The conference call will begin at 8:00 a.m. Eastern time. Investors, media, and the general public can access a live webcast of the conference call through the link that will be posted on Elanco's website at https://investor.elanco.com/events-and-presentations/default.asp
- ANALYSTCitigroup initiated coverage on Elanco Animal Health with a new price targetCitigroup initiated coverage of Elanco Animal Health with a rating of Buy and set a new price target of $30.00
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Elanco Animal Health IncorporatedSCHEDULE 13G/A - Elanco Animal Health Inc (0001739104) (Subject)
- PRElanco Launches Advantage™ Collar for Dogs with Four Months of Continuous Protection from Fleas, Ticks and Mosquitoes*Breaks the flea lifecycle* with Pyriproxyfen, an insect growth regulator, preventing fleas from reinfesting the dogAdjustable collar fits comfortably and securely on a dog of any sizeStrengthens Elanco's 25-year Advantage brand familyAvailable at pet specialty, dollar, grocery and mass retailers, with a suggested retail price below $25**INDIANAPOLIS, April 9, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE:ELAN) today announced the launch of its Advantage™ Collar for Dogs, a new product providing long-lasting protection against two parasites that don't take a season off – fleas and ticks. Designed for dogs and puppies 12 weeks of age and older, this dog collar kills and repels fl
- SECSEC Form DEFA14A filed by Elanco Animal Health IncorporatedDEFA14A - Elanco Animal Health Inc (0001739104) (Filer)
- SECSEC Form DEF 14A filed by Elanco Animal Health IncorporatedDEF 14A - Elanco Animal Health Inc (0001739104) (Filer)
- INSIDERSEC Form 4 filed by Modi Rajeev A.4 - Elanco Animal Health Inc (0001739104) (Issuer)
- INSIDERSEC Form 4 filed by Simmons Jeffrey N4 - Elanco Animal Health Inc (0001739104) (Issuer)
- INSIDERSEC Form 4 filed by Vanhimbergen Robert M4 - Elanco Animal Health Inc (0001739104) (Issuer)
- INSIDERSEC Form 4 filed by De Brabander Ellen4 - Elanco Animal Health Inc (0001739104) (Issuer)
- INSIDERSEC Form 4 filed by Anand Kapila K4 - Elanco Animal Health Inc (0001739104) (Issuer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Elanco Animal Health IncorporatedSCHEDULE 13G/A - Elanco Animal Health Inc (0001739104) (Subject)
- INSIDERSEC Form 4 filed by Simmons Jeffrey N4 - Elanco Animal Health Inc (0001739104) (Issuer)
- INSIDERSEC Form 4 filed by Modi Rajeev A.4 - Elanco Animal Health Inc (0001739104) (Issuer)
- INSIDERSEC Form 4 filed by Vanhimbergen Robert M4 - Elanco Animal Health Inc (0001739104) (Issuer)
- INSIDERSEC Form 4 filed by Officer Modi Rajeev A.4 - Elanco Animal Health Inc (0001739104) (Issuer)
- INSIDERSEC Form 4 filed by PRESIDENT, CEO AND DIRECTOR Simmons Jeffrey N4 - Elanco Animal Health Inc (0001739104) (Issuer)
- INSIDERSEC Form 4 filed by EVP and CFO Vanhimbergen Robert M4 - Elanco Animal Health Inc (0001739104) (Issuer)
- INSIDERSEC Form 4 filed by Officer Correia De Simas Jose Manuel4 - Elanco Animal Health Inc (0001739104) (Issuer)
- INSIDEROfficer Modi Rajeev A. covered exercise/tax liability with 4,392 shares, decreasing direct ownership by 3% to 155,901 units (SEC Form 4)4 - Elanco Animal Health Inc (0001739104) (Issuer)
- INSIDERGC AND CORP SEC O'Neill Shiv covered exercise/tax liability with 4,738 shares, decreasing direct ownership by 5% to 83,834 units (SEC Form 4)4 - Elanco Animal Health Inc (0001739104) (Issuer)
- INSIDERPRESIDENT, CEO AND DIRECTOR Simmons Jeffrey N covered exercise/tax liability with 37,898 units of Common Stock, decreasing direct ownership by 2% to 2,051,898 units (SEC Form 4)4 - Elanco Animal Health Inc (0001739104) (Issuer)